Search filters

List of works by Elizabeth Ahern

An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer

scientific article published on 05 September 2018

Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice.

scientific article published on 20 June 2017

Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study

scientific article published on 9 February 2017

Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis

scholarly article by Heidi Harjunpää et al published 2018 in OncoImmunology

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

scientific article published on 19 December 2019

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

article

Retrospective analysis of hospital admissions due to immune checkpoint inhibitor-induced immune-related adverse events (irAE)

scientific article published on 09 June 2020

Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.

scientific article published on 26 June 2017

Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real-world multi-institution cohort study

scientific article published on 25 September 2020

Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma

scientific article published on 28 April 2020